Resonance Rayleigh scattering assay for EGFR using antibody immobilized gold nanoparticles

Antibody-labeled gold nanoparticle based resonance Rayleigh scattering detection of S100B

Traumatic brain injury (TBI) is a sudden brain injury due to an external force that causes a large number of deaths and permanent disabilities every year. S100B has been recognized as a potential objective quantitative biomarker for screening the prognosis of TBI and severe head injury. In this article, an anti-S100B monoclonal antibody was immobilized on cysteamine (Cy) functionalized gold nanoparticles (AuNPs) by EDC-NHS chemistry, which enabled S100B resonance Rayleigh scattering (RRS) detection based on antibody-labeled gold nanoparticles. The prepared conjugates were characterized by ultraviolet-visible spectroscopy (UV-vis), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), dynamic light scattering (DLS) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Based on the specific binding of the antibody and antigen, the RRS intensities at 381 nm and 541 nm wavelengths were significantly enhanced, and thus a dual wavelength overlapping resonance Rayleigh scattering (DWO-RRS) method was established. The scattering intensity of the two overlapping peaks was proportional to the concentration of S100B in the range of 0.05-4.5 ng mL-1 with a detection limit of 0.002 ng mL-1. The proposed DWO-RRS method is time-saving, simple, sensitive, and can be used to determine the concentration of S100B in human serum with satisfactory results, which has a promising application in the early diagnosis of TBI.

Fullerene carbon dot catalytic amplification-aptamer assay platform for ultratrace As+3 utilizing SERS/RRS/Abs trifunctional Au nanoprobes

Under microwave conditions, Au-doped carbon dots (CD_Au) were prepared using fullerene as a precursor, and characterized in details. It is found that CD_Au can strongly catalyze the reaction of HAuCl₄-fructose to generate gold nanoparticles (AuNPs). The new nanocatalytic reaction was studied by surface-enhanced Raman scattering (SERS), resonance Rayleigh scattering (RRS) and absorption (Abs) spectrometry. Based on the specific aptamer (Apt_As)-As⁺³ reaction mediated the CD_Au-HAuCl₄-fructose nanoreaction, and the products of AuNPs as SERS/RRS/Abs trifunctional indicator nanoprobes, a new trimode Apt assay strategy was developed for detection of ultratrace As⁺³. A 0.07-0.70, 0.10-0.60 and 0.20-0.70 μg L^-1 were determined by SERS, RRS and Abs, with detection limits (DL) of 0.04, 0.06, 0.10 μg L^-1 respectively. The aptamer-regulation CD_Au catalytic amplification platform can be also used to assay 1.7-13.3 nmol L^-1 Pb²⁺ and 2.0-12 μmol L^-1 Hg²⁺, with DL of 0.80 nmol L^-1 and 0.90 μmol L^-1 respectively.